参考文献
[1] Travis RC, Reeves GK, Green J, et al, for the Million Women Study Collaborators. Gene–environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study. Lancet, 2010, published online June 2. DOI:10.1016/S0140-6736(10)60636-8
[2] Wacholder S, Hartge P, Prentice R, et al. Performance of common genetic variants in breast-cancer risk models. N Engl J Med, 2010, 362: 986–93
[3] Million Women Study Collaborators. Breast cancer and hormonereplacement therapy in the Million Women Study. Lancet, 2003, 362: 419–27
[4] Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med, 2007, 356: 1670–74.
[5] Eisen A, Lubinski J, Gronwald J, et al, and the Hereditary Breast Cancer Clinical Study Group. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers. J Natl Cancer Inst, 2008, 100: 1361–67
[6] Cullinane CA, Lubinski J, Neuhausen SL, et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer, 2005, 117: 988–91
[7] Jernströ H, Lubinski J, Lynch HT, et al. Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst, 2004, 96: 1094–98.
|